Marex Group’s Transmedics TMDX Stock Holding History

Marex Group’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,261	Closed	-$254K	–	1134
2025 Q3	$254K	Buy	+2,261	New	+$265K	﹤0.01%	664
2025 Q1	–	Sell	-10,000	Closed	-$624K	–	847
2024 Q4	$624K	Buy	10,000 +4,000	+67%	+$372K	0.01%	304
2024 Q3	$942K	Hold	6,000	–	–	0.02%	219
2024 Q2	$904K	Hold	6,000	–	–	0.02%	227
2024 Q1	$444K	Sell	6,000 -1,006	-14%	-$82.9K	0.01%	268
2023 Q4	$553K	Buy	+7,006	New	+$423K	0.02%	283

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Marex Group's TMDX Position: Q4 2025 in Review

Marex Group sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 2,261 shares — an estimated $254K sold.

Marex Group first reported a position in TMDX in Q4 2023 and held it in 6 quarters. The position peaked at $942K in Q3 2024. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Marex Group reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Marex Group sold 2,261 Transmedics shares in Q4 2025, an estimated $254K.
Marex Group first reported a position in Transmedics in Q4 2023 and held it in 6 quarters.
Marex Group's Transmedics position peaked at $942K in Q3 2024.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.